Blackmores Ltd. receives Investment Bank Analyst Rating Update
By Oliver Gray Investing.com - The S&P/ASX 200 dipped 14.9 points or 0.2% to 7,112.8 during Thursday’s deals, retreating for the first session in four as market participants...
By Oliver Gray Investing.com - The S&P/ASX 200 dipped just 2.9 points or 7488.3 during Friday’s session, extending losses of 0.54% yesterday but closing out the week with modest...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Blackmores Limited develops, sells, and markets natural health products for humans and animals in Australia, New Zealand, Asia, China, and India. The company offers vitamins, and herbal and mineral nutritional supplements. It also provides products for various conditions related to arthritis, joints, bones, and muscles; brain health; cold, flu, and immunity; digestive health; energy and exercise; everyday health; and eye health. In addition, the company offers products in the areas of fish and nutritional oils; heart and circulation; infant nutrition; kids health; men's health; multivitamins; nails, hair, and skin; pet health; probiotics; pregnancy and preconception; stress relief and sleep support; weight management; wellbeing management; and women's health. It provides its products through retail and online channels. The company was founded in 1930 and is headquartered in Sydney, Australia.
|Average||7443.22 (+10462.26% Upside)|
|No. of Analysts||9|